Tiếp theoHướng dẫn tiếp theo
AI Employee Monitoring and Workplace Surveillance
xã hội
HƯỚNG DẪN xã hội
AI in Prescription Drug Monitoring Programs
AI in prescription drug monitoring programs (PDMPs) refers to algorithms, such as Bamboo Health's NarxCare, that analyze a patient's history of controlled-substance prescriptions and produce risk scores that pharmacists and prescribers see when they check the state database.
Trên trang nàyđọc 4 phút
Tổng quan
It matters because these scores can influence whether a prescription is filled or a patient is treated. Critics argue the scores can penalize people with complex medical needs while offering little transparency or way to appeal.
Lặn sâu
Almost every US state runs a PDMP: a database where pharmacies report dispensed controlled substances. Clinicians and pharmacists check it before prescribing or dispensing. Many states and pharmacy systems add NarxCare, a platform from Bamboo Health (formerly Appriss Health), which displays analytics on top of the raw history. NarxCare shows separate Narx scores for narcotics, sedatives and stimulants. Each is a three-digit number from 000 to 999, and the last digit shows how many active prescriptions of that type the patient has. It also shows an Overdose Risk Score and visual summaries. The inputs are patterns in the records: how many prescribers and pharmacies are involved, total dose (often expressed in morphine milligram equivalents), overlapping prescriptions and how recent the fills are. For pharmacists the stakes are specific. Under federal rules, pharmacists share a 'corresponding responsibility' with the prescriber to make sure a controlled-substance prescription serves a legitimate medical purpose. A high score can prompt a call to the prescriber, a delay, a refusal to fill, or an offer of naloxone. Bamboo Health has said the scores are not meant to be the sole basis for clinical decisions. The CDC's 2022 opioid prescribing guideline also warns clinicians against dismissing patients based on PDMP information. There are several main criticisms. The model is proprietary, so patients and clinicians cannot see exactly how a score was calculated. People with cancer, chronic pain or multiple specialists naturally have more prescribers and pharmacies. Pet prescriptions filled under an owner's name can raise the owner's score. Legal scholars, including Jennifer Oliva, have argued these tools can discriminate against patients with disabilities or complex conditions. There is also no standard way for patients to see or dispute a score. A common misconception is that a high score means addiction or diversion. It reflects a pattern of prescriptions, not a diagnosis of the patient.
Tác động chiến lược
Rủi ro và an toàn
Những tác hại thảm khốc và thường ngày của AI đều phụ thuộc vào việc ai hiểu được rủi ro và ai có thể hành động.
Quyết định rõ ràng hơn
Kiến thức công cộng và chuyên môn định hình liệu chính sách an toàn mạnh mẽ có khả thi về mặt chính trị hay không.
Phá vỡ sự thổi phồng
Những lời giải thích rõ ràng làm giảm sự thu hút bởi sự cường điệu, PR trong phòng thí nghiệm và sân khấu đạo đức mơ hồ.
The Future of AI in Prescription Drug Monitoring Programs
Pressure for transparency is growing. Pain-patient advocates, legal scholars and some clinicians want disclosure of the inputs, validation results broken down by patient group, and a way for patients to see and correct their records. Some states may add rules about how scores can be used in dispensing decisions, though the approach varies. Better separation of veterinary prescriptions and better record matching would remove known sources of error. How far these tools actually reduce overdoses while protecting access for legitimate patients is still an open question that needs independent evaluation.
Triển khai trong thế giới thực
A pharmacist sees a high narcotic score for a patient filling an oxycodone prescription. He opens the full PDMP history and finds prescriptions from one oncologist and one surgeon after a documented cancer surgery, so he fills it and offers naloxone.
A patient's sedative score rises because of benzodiazepine prescriptions written for her dog, which were recorded under her name. Her pharmacist has to call the veterinarian to confirm the explanation.
A pharmacy chain's policy says a high score alone is not a reason to refuse. Pharmacists must look at specific warning signs, such as overlapping prescriptions from unrelated prescribers, and speak with the prescriber.
A pain clinic sees a patient whose record shows many pharmacies. The pharmacies turn out to reflect insurance changes and drug shortages, which shows how a factor the score counts can have an ordinary explanation.
Rủi ro & lan can
Xử lý rủi ro hiện hữu như khoa học viễn tưởng trong khi khả năng lại phức tạp.
Nhầm lẫn giữa an toàn sản phẩm bề mặt với sự liên kết dưới quyền tự chủ cao.
Chỉ để lại những khán giả không phải người Anh và không có chuyên môn với những nguồn chất lượng thấp.
Lộ trình thực hiện
Tách biệt các tác hại của sản phẩm, sử dụng sai và rủi ro mất kiểm soát/sai lệch.
Hỏi bằng chứng nào sẽ thay đổi quan điểm của bạn về thời gian và mức độ nghiêm trọng.
Ưu tiên các nguồn chính và đánh giá cụ thể hơn các tuyên bố tiếp thị.
Xác định một lộ trình hành động: sự nghiệp, chính sách, nguồn tài trợ hoặc kỹ năng - không chỉ là nhận thức.
Tiếp tục khám phá
Free newsletter
Get the daily AI briefing
Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.
One email each weekday. Unsubscribe in one click. We never sell or share your address.
Test yourself
Take the AI in Prescription Drug Monitoring Programs quiz
Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.
Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation
Câu hỏi thường gặp
What is AI in Prescription Drug Monitoring Programs?
AI in prescription drug monitoring programs (PDMPs) refers to algorithms, such as Bamboo Health's NarxCare, that analyze a patient's history of controlled-substance prescriptions and produce risk scores that pharmacists and prescribers see when they check the state database. It matters because these scores can influence whether a prescription is filled or a patient is treated. Critics argue the scores can penalize people with complex medical needs while offering little transparency or way to appeal.
In a NarxCare narcotic score of 452, what does the final digit 2 represent?
The last digit of each three-digit Narx score shows how many active prescriptions of that type the patient has.
Why can a dog's benzodiazepine prescription raise its owner's sedative score?
When pet prescriptions are recorded under the owner, they look like the owner's own fills and push the score up.
Under federal rules, what 'corresponding responsibility' do pharmacists share with prescribers?
Pharmacists share responsibility for making sure controlled-substance prescriptions are legitimate, which is why a score can affect whether they fill one.
What does the CDC's 2022 opioid guideline warn clinicians against, as noted in the guide?
The guideline cautions against dismissing patients because of PDMP findings, which fits with the view that scores should not decide care by themselves.
A patient with cancer sees an oncologist, a surgeon and a pain specialist. Why might their score be high even with appropriate care?
Having several prescribers and pharmacies is an input to the score. Complex but legitimate care produces the same pattern the model treats as risky.
Tiếp tục học hỏi
Hướng dẫn liên quan
Đã chọn thêm hướng dẫn cho chủ đề này